AR121608A1 - Cápsulas blandas de gel - Google Patents
Cápsulas blandas de gelInfo
- Publication number
- AR121608A1 AR121608A1 ARP210100679A ARP210100679A AR121608A1 AR 121608 A1 AR121608 A1 AR 121608A1 AR P210100679 A ARP210100679 A AR P210100679A AR P210100679 A ARP210100679 A AR P210100679A AR 121608 A1 AR121608 A1 AR 121608A1
- Authority
- AR
- Argentina
- Prior art keywords
- soft gel
- gel capsules
- shell composition
- solubilizes
- certain embodiments
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062991354P | 2020-03-18 | 2020-03-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR121608A1 true AR121608A1 (es) | 2022-06-22 |
Family
ID=77771391
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP210100679A AR121608A1 (es) | 2020-03-18 | 2021-03-18 | Cápsulas blandas de gel |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230172864A1 (https=) |
| EP (1) | EP4121036A4 (https=) |
| JP (2) | JP7785682B2 (https=) |
| KR (1) | KR20220154196A (https=) |
| AR (1) | AR121608A1 (https=) |
| AU (1) | AU2021238345A1 (https=) |
| BR (1) | BR112022018268A2 (https=) |
| CA (1) | CA3171512A1 (https=) |
| CO (1) | CO2022014130A2 (https=) |
| MX (1) | MX2022011549A (https=) |
| WO (1) | WO2021188773A1 (https=) |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030133939A1 (en) * | 2001-01-17 | 2003-07-17 | Genecraft, Inc. | Binding domain-immunoglobulin fusion proteins |
| EP1545477A4 (en) * | 2002-09-13 | 2006-11-22 | Cydex Inc | CAPSULES CONTAINING AQUEOUS FILLING COMPOSITIONS STABILIZED WITH DERIVED CYCLODEXTRIN |
| ITMI20022777A1 (it) * | 2002-12-27 | 2004-06-28 | Altergon Sa | Formulazioni farmaceutiche per ormoni tiroidei e procedimenti per il loro ottenimento. |
| EP2444071A1 (en) * | 2004-09-27 | 2012-04-25 | Sigmoid Pharma Limited | Minicapsule formulations |
| CN1872061A (zh) * | 2006-04-17 | 2006-12-06 | 宛六一 | 一种药物组合物软胶囊及其制备方法 |
| JP5840668B2 (ja) * | 2012-12-07 | 2016-01-06 | 富士カプセル株式会社 | ロキソプロフェンナトリウム含有軟カプセル用内容物、及び、それを含有する軟カプセル製剤 |
| US10420729B2 (en) * | 2013-03-15 | 2019-09-24 | R.P. Scherer Technologies, Llc | Abuse resistant capsule |
| US9326947B1 (en) * | 2014-02-28 | 2016-05-03 | Banner Life Sciences Llc | Controlled release fumarate esters |
| US9775814B2 (en) * | 2014-06-20 | 2017-10-03 | Patheon Softgels Inc. | Enteric soft capsule compositions |
| US20150366814A1 (en) * | 2014-06-23 | 2015-12-24 | Banner Life Sciences Llc | All-natural enteric soft capsules comprising active ingredients |
| ES2787220T3 (es) * | 2015-03-26 | 2020-10-15 | Patheon Softgels Inc | Cápsulas blandas llenas de líquido |
| US20180049999A1 (en) * | 2015-04-14 | 2018-02-22 | Atossa Genetics Inc. | Compositions and methods of treatment of breast disorders and estrogen-related disorders |
| US20170119680A1 (en) * | 2015-10-30 | 2017-05-04 | R.P. Scherer Technologies, Llc | Extended release film-coated capsules |
| IL316439A (en) * | 2018-03-15 | 2024-12-01 | Scherer Technologies Llc R P | Enteric softgel capsules |
| IT201800003615A1 (it) * | 2018-03-15 | 2019-09-15 | Altergon Sa | Formulazioni altamente stabili di ormone tiroideo in capsule molli |
-
2021
- 2021-03-18 JP JP2022555945A patent/JP7785682B2/ja active Active
- 2021-03-18 MX MX2022011549A patent/MX2022011549A/es unknown
- 2021-03-18 AR ARP210100679A patent/AR121608A1/es unknown
- 2021-03-18 CA CA3171512A patent/CA3171512A1/en active Pending
- 2021-03-18 US US17/910,999 patent/US20230172864A1/en active Pending
- 2021-03-18 AU AU2021238345A patent/AU2021238345A1/en active Pending
- 2021-03-18 WO PCT/US2021/022918 patent/WO2021188773A1/en not_active Ceased
- 2021-03-18 EP EP21771183.7A patent/EP4121036A4/en active Pending
- 2021-03-18 KR KR1020227035608A patent/KR20220154196A/ko active Pending
- 2021-03-18 BR BR112022018268A patent/BR112022018268A2/pt unknown
-
2022
- 2022-09-30 CO CONC2022/0014130A patent/CO2022014130A2/es unknown
-
2025
- 2025-12-03 JP JP2025225446A patent/JP2026035788A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4121036A4 (en) | 2024-04-10 |
| CO2022014130A2 (es) | 2022-10-31 |
| US20230172864A1 (en) | 2023-06-08 |
| EP4121036A1 (en) | 2023-01-25 |
| JP2023518245A (ja) | 2023-04-28 |
| MX2022011549A (es) | 2022-10-13 |
| JP2026035788A (ja) | 2026-03-04 |
| KR20220154196A (ko) | 2022-11-21 |
| BR112022018268A2 (pt) | 2022-10-25 |
| AU2021238345A1 (en) | 2022-10-06 |
| JP7785682B2 (ja) | 2025-12-15 |
| WO2021188773A1 (en) | 2021-09-23 |
| CA3171512A1 (en) | 2022-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8504366A1 (es) | Perfeccionamientos en un dispositivo para obturar el espacio entre un eje rotatorio y un organo fijo que rodea al eje | |
| Hegde et al. | Sealing ability of a novel hydrophilic vs. conventional hydrophobic obturation systems: A bacterial leakage study | |
| PE20001322A1 (es) | Composicion multiparticula de liberacion modificada | |
| AR124044A1 (es) | Cápsulas blandas de liberación retardada | |
| ES411206A1 (es) | Una disposicion mejorada de embase unitario reactivo con elagua. | |
| PT1809261E (pt) | Sistema de cápsula mole não gelatinosa | |
| ES8602393A1 (es) | Procedimiento para preparar una composicion para acondicionamiento de los cabellos | |
| MX2022013695A (es) | Composicion encapsulada de microcapsulas de nucleo-cubierta y proceso para su preparacion. | |
| Turk et al. | Effect of final irrigation procedures on fracture resistance of root filled teeth: an ex vivo study | |
| AR121608A1 (es) | Cápsulas blandas de gel | |
| HUP9701111A2 (hu) | Töltőanyag lágy zselatin kapszula gyógyszeradagolási formához | |
| ATE252376T1 (de) | Retinolhaltiges arzneimittel kompatibel mit weichgelatinekapseln | |
| MX2024000409A (es) | Capsula de gelatina blanda. | |
| AR027748A1 (es) | Pequenas esferas o globulos que contienen estavudina y permiten la liberacion controlada de la misma | |
| AR114434A1 (es) | Cápsulas de gelatina blanda entéricas | |
| DE69819356D1 (de) | Vitamin zusammensetzung | |
| MX2022006680A (es) | Codificador, decodificador, metodo de codificacion y metodo de decodificacion. | |
| BR112022005755A2 (pt) | Formulações de cápsula de gel macio não animal, métodos de preparação, e métodos de uso das mesmas | |
| EP4398004A3 (en) | Cationic contact lens | |
| BR112022024391A2 (pt) | Cápsulas de gelatina mole para liberação retardada | |
| CO2025011936A2 (es) | Cápsulas farmacéuticas osmóticas | |
| Bachour et al. | Evaluation of the rupture test for stability studies of soft-shell capsules | |
| HUP9701112A2 (hu) | Antiflatulenst tartalmazó töltőanyag lágy zselatin kapszula gyógyszeradagolási formához | |
| ZA202401508B (en) | Films and capsules | |
| PT942702E (pt) | Dispositivo de aprovisionamento de mechas medicinais |